Impact of a Patient Blood Management monitoring and feedback programme on allogeneic blood transfusions and related costs.


Journal

Anaesthesia
ISSN: 1365-2044
Titre abrégé: Anaesthesia
Pays: England
ID NLM: 0370524

Informations de publication

Date de publication:
Dec 2019
Historique:
accepted: 29 07 2019
pubmed: 27 8 2019
medline: 12 11 2019
entrez: 27 8 2019
Statut: ppublish

Résumé

A Patient Blood Management programme was established at the University Hospital of Zurich, along with a monitoring and feedback programme, at the beginning of 2014 with a first analysis reported in 2015. Our study aimed to investigate the further impact of this Patient Blood Management monitoring and feedback programme on transfusion requirements and related costs. We included adult patients discharged between 2012 and 2017. A total of 213,882 patients underwent analysis: 66,659 patients in the baseline period (2012-2013); 35,309 patients in the year after the introduction of the Patient Blood Management monitoring and feedback programme (2014) and 111,914 patients in the continued sustainability period (2015-2017). The introduction of the Patient Blood Management monitoring and feedback programme reduced allogeneic blood product transfusions by 35%, from 825 units per 1000 hospital discharges in 2012 to 536 units in 2017. The most sustained effect was an approximately 40% reduction in red blood cell transfusions, from 535 per 1000 discharges to 319 units. Fewer patients were transfused in the periods after the introduction of the Patient Blood Management monitoring and feedback programme (6251 (9.4%) vs. 2932 (8.3%) vs. 8196 (7.3%); p < 0.001). Compared with 2012, the yearly OR for being exposed to any blood transfusion declined steadily after the introduction of the Patient Blood Management monitoring and feedback programme to 0.64 (95%CI 0.61-0.68; p < 0.001) in 2017. For patients requiring extracorporeal membrane oxygenation, transfusion requirements were also sustainably reduced. This reduction in allogeneic blood transfusions led to savings of 12,713,754 Swiss francs (£ 9,497,000 sterling; EUR 11,100,000; US$ 12,440,000) in blood product acquisition costs over 4 years. In-hospital mortality was not affected by the programme. The Patient Blood Management monitoring and feedback programme sustainably reduced transfusion requirements and related costs, without affecting in-hospital mortality.

Identifiants

pubmed: 31448406
doi: 10.1111/anae.14816
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1534-1541

Informations de copyright

© 2019 Association of Anaesthetists.

Références

Isbister JP. The three-pillar matrix of patient blood management. International Society of Blood Transfusion Science Series 2015; 10: 286-94.
Althoff FC, Neb H, Herrmann E, et al. Multimodal patient blood management program based on a three-pillar strategy. A systematic review and meta-analysis. Annals of Surgery 2019; 269: 794-804.
Publications Office of the European Union. Supporting Patient Blood Management (PBM) in the EU. A Practical Implementation Guide for Hospitals. 2017. https://publications.europa.eu/en/publication-detail/-/publication/93e1bbbf-1a8b-11e7-808e-01aa75ed71a1/language-en (accessed 23/07/2019).
World Health Organization. WHA63.12 Agenda item 11.17 Availability, safety and quality of blood products. 2010. http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R12-en.pdf (accessed 23/07/2019).
Muñoz M, Acheson AG, Auerbach M, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 2017; 72: 233-47.
Meybohm P, Richards T, Isbister J, et al. Patient blood management bundles to facilitate implementation. Transfusion Medicine Reviews 2017; 31: 62-71.
Mueller MM, Van Remoortel H, Meybohm P, et al. Patient Blood Management. Recommendations from the 2018 Frankfurt Consensus Conference. Journal of the American Medical Association 2018; 2019: 983-97.
Butler CE, Noel S, Hibbs SP, et al. Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients. Transfusion 2015; 55: 1964-71.
Mehra T, Seifert B, Bravo-Reiter S, et al. Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. Transfusion 2015; 55: 2807-15.
Leahy MF, Hofmann A, Towler S, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion 2017; 57: 1347-58.
Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50: 753-65.
Shander A, Ozawa S, Hofmann A. Activity-based costs of plasma transfusions in medical and surgical inpatients at a US hospital. Vox Sanguinis 2016; 111: 55-61.
Charleston SC. The cost of blood: multidisciplinary consensus conference for a standard methodology. Transfusion Medicine Reviews 2005; 19: 66-78.
Abraham I, Sun D. The cost of blood transfusion in Western Europe as estimated from six studies. Transfusion 2012; 52: 1983-8.
Shander A, Hofmann A, Gombotz H, Theusinger OM, Spahn DR. Estimating the cost of blood: past, present, and future directions. Best Practice and Research Clinical Anaesthesiology 2007; 21: 271-89.
Kleinerüschkamp A, Meybohm P, Straub N, Zacharowski K, Choorapoikayil S. A model-based cost-effectiveness analysis of patient blood management. Blood Transfusion 2019; 17: 16-26.
Esper SA, Levy JH, Waters JH, Welsby IJ. Extracorporeal membrane oxygenation in the adult: a review of anticoagulation monitoring and transfusion. Anesthesia and Analgesia 2014; 118: 731-43.
Menaker J, Galvagno S, Rabinowitz R, et al. Epidemiology of blood stream infection in adult extracorporeal membrane oxygenation patients: a cohort study. Heart and Lung 2019; 48: 236-9.
Na SJ, Chung CR, Choi HJ, et al. Blood stream infection in patients on venovenous extracorporeal membrane oxygenation for respiratory failure. Infection Control and Hospital Epidemiology 2018; 39: 871-4.
Simon GI, Craswell A, Thom O, Fung YL. Outcomes of restrictive versus liberal transfusion strategies in older adults from nine randomised controlled trials: a systematic review and meta-analysis. Lancet Haematology 2017; 4: e465-74.
Carson JL, Stanworth SJ, Roubinian N, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2016; 10: CD002042.
Thakkar RN, Lee KHK, Ness PM, et al. Relative impact of a patient blood management program on utilization of all three major blood components. Transfusion 2016; 56: 2212-20.
Zuckerberg GS, Scott AV, Wasey JO, et al. Efficacy of education followed by computerized provider order entry with clinician decision support to reduce red blood cell utilization. Transfusion 2015; 55: 1628-36.

Auteurs

A Kaserer (A)

Institute of Anaesthesiology, University of Zurich and University Hospital Zurich, Switzerland.

J Rössler (J)

Institute of Anaesthesiology, University of Zurich and University Hospital Zurich, Switzerland.

J Braun (J)

Department of Biostatistics, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland.

F Farokhzad (F)

Medical Directorate, University of Zurich and University Hospital Zurich, Switzerland.

H-C Pape (HC)

Department of Surgery, University of Zurich and University Hospital Zurich, Switzerland.

P Dutkowski (P)

Department of Surgery, University of Zurich and University Hospital Zurich, Switzerland.

A Plass (A)

Department of Surgery, University of Zurich and University Hospital Zurich, Switzerland.

T Horisberger (T)

Institute of Anaesthesiology, University of Zurich and University Hospital Zurich, Switzerland.

J Volbracht (J)

Medical Directorate, University of Zurich and University Hospital Zurich, Switzerland.

M G Manz (MG)

Department of Medical Oncology and Haematology, University of Zurich and University Hospital Zurich, Switzerland.

D R Spahn (DR)

Institute of Anaesthesiology, University of Zurich and University Hospital Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH